메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: A multi-centre study to optimise drug therapy during ECMO

Author keywords

Analgesics; Antibiotics; Drug toxicity; ECMO; Pharmacodynamics; Pharmacokinetics; Sedatives; Therapeutic failure

Indexed keywords

ALBUMIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BILIRUBIN; CASPOFUNGIN; CEFTRIAXONE; CIPROFLOXACIN; CREATININE; DEXMEDETOMIDINE; FENTANYL; FLUCONAZOLE; GENTAMICIN; LINEZOLID; MEROPENEM; MIDAZOLAM; MORPHINE; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; SEDATIVE AGENT; THIOPENTAL; TIMENTIN; VANCOMYCIN; VORICONAZOLE;

EID: 84870061354     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-12-29     Document Type: Article
Times cited : (87)

References (39)
  • 3
    • 84856747311 scopus 로고    scopus 로고
    • Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era
    • 10.1007/s00134-011-2439-2, 22147116
    • MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012, 38(2):210-220. 10.1007/s00134-011-2439-2, 22147116.
    • (2012) Intensive Care Med , vol.38 , Issue.2 , pp. 210-220
    • MacLaren, G.1    Combes, A.2    Bartlett, R.H.3
  • 4
    • 84873073107 scopus 로고    scopus 로고
    • Ann Arbor( MI), ECLS Registry report
    • ECLS Registry report Extracorporeal Life Support Organisation 2011, Ann Arbor( MI), ECLS Registry report.
    • (2011) Extracorporeal Life Support Organisation
  • 6
    • 70350018319 scopus 로고    scopus 로고
    • Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
    • 10.1016/S0140-6736(09)61069-2, 19762075
    • Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075.
    • (2009) Lancet , vol.374 , Issue.9698 , pp. 1351-1363
    • Peek, G.J.1    Mugford, M.2    Tiruvoipati, R.3    Wilson, A.4    Allen, E.5    Thalanany, M.M.6    Hibbert, C.L.7    Truesdale, A.8    Clemens, F.9    Cooper, N.10
  • 7
    • 0034041062 scopus 로고    scopus 로고
    • Extracorporeal membrane oxygenation for severe acute respiratory failure
    • 10.1186/cc689, 137254, 11094500
    • Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000, 4(3):156-168. 10.1186/cc689, 137254, 11094500.
    • (2000) Crit Care , vol.4 , Issue.3 , pp. 156-168
    • Lewandowski, K.1
  • 8
    • 84860229974 scopus 로고    scopus 로고
    • Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy - a multicentre pharmacokinetic study
    • 10.1097/CCM.0b013e318241e553, 22511133
    • Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy - a multicentre pharmacokinetic study. Crit Care Med 2012, 40(5):1523-1528. 10.1097/CCM.0b013e318241e553, 22511133.
    • (2012) Crit Care Med , vol.40 , Issue.5 , pp. 1523-1528
    • Roberts, D.M.1    Roberts, J.A.2    Roberts, M.S.3    Liu, X.4    Nair, P.5    Cole, L.6    Lipman, J.7    Bellomo, R.8
  • 9
    • 84863807810 scopus 로고    scopus 로고
    • Sub-therapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations
    • 10.1378/chest.11-1671, 22194591
    • Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney B, Ungerer J, Lipman J, Roberts JA. Sub-therapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 2012, 142(1):30-39. 10.1378/chest.11-1671, 22194591.
    • (2012) Chest , vol.142 , Issue.1 , pp. 30-39
    • Udy, A.A.1    Varghese, J.M.2    Altukroni, M.3    Briscoe, S.4    McWhinney, B.5    Ungerer, J.6    Lipman, J.7    Roberts, J.A.8
  • 10
    • 81555208494 scopus 로고    scopus 로고
    • Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using monte carlo simulations to predict doses for specified pharmacodynamic targets
    • 10.1128/AAC.00424-11, 3232768, 21930888
    • Patel K, Roberts JA, Lipman J, Tett SE, Deldot ME, Kirkpatrick CM. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using monte carlo simulations to predict doses for specified pharmacodynamic targets. Antimicrob Agents Chemother 2011, 55(12):5868-5873. 10.1128/AAC.00424-11, 3232768, 21930888.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.12 , pp. 5868-5873
    • Patel, K.1    Roberts, J.A.2    Lipman, J.3    Tett, S.E.4    Deldot, M.E.5    Kirkpatrick, C.M.6
  • 11
    • 79956324640 scopus 로고    scopus 로고
    • Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens
    • 10.1128/AAC.01708-10, 3101407, 21402850
    • Roberts JA, Taccone FS, Udy AA, Vincent JL, Jacobs F, Lipman J. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 2011, 55(6):2704-2709. 10.1128/AAC.01708-10, 3101407, 21402850.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.6 , pp. 2704-2709
    • Roberts, J.A.1    Taccone, F.S.2    Udy, A.A.3    Vincent, J.L.4    Jacobs, F.5    Lipman, J.6
  • 12
    • 84870707254 scopus 로고    scopus 로고
    • Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation
    • Epub ahed of print
    • Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012, Epub ahed of print.
    • (2012) J Crit Care
    • Shekar, K.1    Fraser, J.F.2    Smith, M.T.3    Roberts, J.A.4
  • 13
    • 0038696153 scopus 로고    scopus 로고
    • Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates
    • 10.2165/00003088-200342050-00001, 12739981
    • Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 2003, 42(5):403-417. 10.2165/00003088-200342050-00001, 12739981.
    • (2003) Clin Pharmacokinet , vol.42 , Issue.5 , pp. 403-417
    • Buck, M.L.1
  • 14
    • 0037472059 scopus 로고    scopus 로고
    • Pharmacokinetics in the newborn
    • 10.1016/S0169-409X(03)00030-9, 12706549
    • Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003, 55(5):667-686. 10.1016/S0169-409X(03)00030-9, 12706549.
    • (2003) Adv Drug Deliv Rev , vol.55 , Issue.5 , pp. 667-686
    • Alcorn, J.1    McNamara, P.J.2
  • 19
    • 78649304589 scopus 로고    scopus 로고
    • Determinants of drug absorption in different ECMO circuits
    • 10.1007/s00134-010-2041-z, 2981740, 20862453
    • Wildschut ED, Ahsman MJ, Allegaert K, Mathot RA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010, 36(12):2109-2116. 10.1007/s00134-010-2041-z, 2981740, 20862453.
    • (2010) Intensive Care Med , vol.36 , Issue.12 , pp. 2109-2116
    • Wildschut, E.D.1    Ahsman, M.J.2    Allegaert, K.3    Mathot, R.A.4    Tibboel, D.5
  • 20
    • 0026568933 scopus 로고
    • Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation
    • Bhatt-Mehta V, Johnson CE, Schumacher RE. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 1992, 12(1):28-32.
    • (1992) Pharmacotherapy , vol.12 , Issue.1 , pp. 28-32
    • Bhatt-Mehta, V.1    Johnson, C.E.2    Schumacher, R.E.3
  • 21
    • 0025371959 scopus 로고
    • In vitro variability in fentanyl absorption by different membrane oxygenators
    • 10.1016/0888-6296(90)90041-D, 2131883
    • Rosen DA, Rosen KR, Silvasi DL. In vitro variability in fentanyl absorption by different membrane oxygenators. J Cardiothorac Anesth 1990, 4(3):332-335. 10.1016/0888-6296(90)90041-D, 2131883.
    • (1990) J Cardiothorac Anesth , vol.4 , Issue.3 , pp. 332-335
    • Rosen, D.A.1    Rosen, K.R.2    Silvasi, D.L.3
  • 23
    • 79951562557 scopus 로고    scopus 로고
    • Antibiotic dosing in the 'at risk' critically ill patient: linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients
    • 10.1186/1471-2253-11-3, 3050838, 21333028
    • Roberts JA, Roberts MS, Semark A, Udy AA, Kirkpatrick CM, Paterson DL, Roberts MJ, Kruger P, Lipman J. Antibiotic dosing in the 'at risk' critically ill patient: linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011, 11:3. 10.1186/1471-2253-11-3, 3050838, 21333028.
    • (2011) BMC Anesthesiol , vol.11 , pp. 3
    • Roberts, J.A.1    Roberts, M.S.2    Semark, A.3    Udy, A.A.4    Kirkpatrick, C.M.5    Paterson, D.L.6    Roberts, M.J.7    Kruger, P.8    Lipman, J.9
  • 24
    • 84857060629 scopus 로고    scopus 로고
    • How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics
    • 10.1016/j.ijantimicag.2011.11.002, 22226651
    • Roberts JA, Joynt GM, Choi GY, Gomersall CD, Lipman J. How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2012, 39(3):187-192. 10.1016/j.ijantimicag.2011.11.002, 22226651.
    • (2012) Int J Antimicrob Agents , vol.39 , Issue.3 , pp. 187-192
    • Roberts, J.A.1    Joynt, G.M.2    Choi, G.Y.3    Gomersall, C.D.4    Lipman, J.5
  • 25
    • 83155166316 scopus 로고    scopus 로고
    • Using PK/PD to optimize antibiotic dosing for critically Ill patients
    • 10.2174/138920111798808329, 21554211
    • Roberts JA. Using PK/PD to optimize antibiotic dosing for critically Ill patients. Curr Pharm Biotechnol 2011, 12(12):2070-2079. 10.2174/138920111798808329, 21554211.
    • (2011) Curr Pharm Biotechnol , vol.12 , Issue.12 , pp. 2070-2079
    • Roberts, J.A.1
  • 27
    • 0037352377 scopus 로고    scopus 로고
    • Bispectral index in the intensive care setting
    • author reply 998-999, 10.1097/01.CCM.0000055393.30990.1E, 12627033
    • Dasta JF, Kane SL, Gerlach AT, Cook CH. Bispectral index in the intensive care setting. Crit Care Med 2003, 31(3):998. author reply 998-999, 10.1097/01.CCM.0000055393.30990.1E, 12627033.
    • (2003) Crit Care Med , vol.31 , Issue.3 , pp. 998
    • Dasta, J.F.1    Kane, S.L.2    Gerlach, A.T.3    Cook, C.H.4
  • 28
    • 84864919590 scopus 로고    scopus 로고
    • High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS
    • Ghassabian S, Moosavi SM, Valero YG, Shekar K, Fraser JF, Smith MT. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012, 903:126-133.
    • (2012) J Chromatogr B Analyt Technol Biomed Life Sci , vol.903 , pp. 126-133
    • Ghassabian, S.1    Moosavi, S.M.2    Valero, Y.G.3    Shekar, K.4    Fraser, J.F.5    Smith, M.T.6
  • 29
    • 78651413706 scopus 로고    scopus 로고
    • Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients
    • 10.1093/jac/dkq449, 21118912
    • Roberts JA, Kirkpatrick CM, Lipman J. Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients. J Antimicrob Chemother 2011, 66(2):227-231. 10.1093/jac/dkq449, 21118912.
    • (2011) J Antimicrob Chemother , vol.66 , Issue.2 , pp. 227-231
    • Roberts, J.A.1    Kirkpatrick, C.M.2    Lipman, J.3
  • 30
    • 77956115684 scopus 로고    scopus 로고
    • Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury
    • 10.1128/AAC.00222-10, 2934958, 20547809
    • Roberts JA, Field J, Visser A, Whitbread R, Tallot M, Lipman J, Kirkpatrick CM. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. Antimicrob Agents Chemother 2010, 54(9):3635-3640. 10.1128/AAC.00222-10, 2934958, 20547809.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.9 , pp. 3635-3640
    • Roberts, J.A.1    Field, J.2    Visser, A.3    Whitbread, R.4    Tallot, M.5    Lipman, J.6    Kirkpatrick, C.M.7
  • 31
    • 67449090359 scopus 로고    scopus 로고
    • Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte carlo dosing simulations and subcutaneous tissue distribution
    • 10.1093/jac/dkp139, 19398460
    • Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 2009, 64(1):142-150. 10.1093/jac/dkp139, 19398460.
    • (2009) J Antimicrob Chemother , vol.64 , Issue.1 , pp. 142-150
    • Roberts, J.A.1    Kirkpatrick, C.M.2    Roberts, M.S.3    Robertson, T.A.4    Dalley, A.J.5    Lipman, J.6
  • 32
    • 72449120921 scopus 로고    scopus 로고
    • First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
    • 10.1016/j.ijantimicag.2009.10.008, 20018492
    • Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents 2010, 35(2):156-163. 10.1016/j.ijantimicag.2009.10.008, 20018492.
    • (2010) Int J Antimicrob Agents , vol.35 , Issue.2 , pp. 156-163
    • Roberts, J.A.1    Kirkpatrick, C.M.2    Roberts, M.S.3    Dalley, A.J.4    Lipman, J.5
  • 33
    • 82955182471 scopus 로고    scopus 로고
    • Relevance of pharmacokinetics to antibiotic dosing in critically ill patients
    • 10.2174/138920111798808310, 22432877
    • Roberts JA. Relevance of pharmacokinetics to antibiotic dosing in critically ill patients. Curr Pharm Biotechnol 2011, 12(12):1981-1982. 10.2174/138920111798808310, 22432877.
    • (2011) Curr Pharm Biotechnol , vol.12 , Issue.12 , pp. 1981-1982
    • Roberts, J.A.1
  • 34
    • 62849095029 scopus 로고    scopus 로고
    • Pharmacokinetic issues for antibiotics in the critically ill patient
    • quiz 859, 10.1097/CCM.0b013e3181961bff, 19237886
    • Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009, 37(3):840-851. quiz 859, 10.1097/CCM.0b013e3181961bff, 19237886.
    • (2009) Crit Care Med , vol.37 , Issue.3 , pp. 840-851
    • Roberts, J.A.1    Lipman, J.2
  • 37
    • 84857854451 scopus 로고    scopus 로고
    • Sedation and analgesia in the mechanically ventilated patient
    • 10.1164/rccm.201102-0273CI, 22016443
    • Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med 2012, 185(5):486-497. 10.1164/rccm.201102-0273CI, 22016443.
    • (2012) Am J Respir Crit Care Med , vol.185 , Issue.5 , pp. 486-497
    • Patel, S.B.1    Kress, J.P.2
  • 38
    • 0034902666 scopus 로고    scopus 로고
    • Optimizing antibiotic therapy in the intensive care unit setting
    • 10.1186/cc1022, 137278, 11511331
    • Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 2001, 5(4):189-195. 10.1186/cc1022, 137278, 11511331.
    • (2001) Crit Care , vol.5 , Issue.4 , pp. 189-195
    • Kollef, M.H.1
  • 39
    • 0034457796 scopus 로고    scopus 로고
    • Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients
    • Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131.
    • (2000) Clin Infect Dis , vol.31 , Issue.SUPPL. 4
    • Kollef, M.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.